Zoetis Inc. (ZTS)

USD 167.01

(-2.21%)

Long Term Debt Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual long term debt in 2023 was 6.56 Billion USD , down -2.58% from previous year.
  • Zoetis Inc.'s latest quarterly long term debt in 2024 Q3 was 6.75 Billion USD , up 0.17% from previous quarter.
  • Zoetis Inc. reported annual long term debt of 6.73 Billion USD in 2022, down -0.07% from previous year.
  • Zoetis Inc. reported annual long term debt of 6.74 Billion USD in 2021, down -0.22% from previous year.
  • Zoetis Inc. reported quarterly long term debt of 6.75 Billion USD for 2024 Q3, up 0.17% from previous quarter.
  • Zoetis Inc. reported quarterly long term debt of 6.56 Billion USD for 2024 Q2, up 0.02% from previous quarter.

Annual Long Term Debt Chart of Zoetis Inc. (2023 - 2010)

Historical Annual Long Term Debt of Zoetis Inc. (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 6.56 Billion USD -2.58%
2022 6.73 Billion USD -0.07%
2021 6.74 Billion USD -0.22%
2020 6.75 Billion USD 10.59%
2019 6.11 Billion USD -5.15%
2018 6.44 Billion USD 30.08%
2017 4.95 Billion USD 10.85%
2016 4.46 Billion USD 0.11%
2015 4.46 Billion USD 22.51%
2014 3.64 Billion USD 0.03%
2013 3.64 Billion USD 615.52%
2012 509 Million USD -11.48%
2011 575 Million USD -14.56%
2010 673 Million USD 0.0%

Peer Long Term Debt Comparison of Zoetis Inc.

Name Long Term Debt Long Term Debt Difference
Amneal Pharmaceuticals, Inc. 2.52 Billion USD -160.177%
Bausch Health Companies Inc. 21.93 Billion USD 70.079%
Catalent, Inc. 4.54 Billion USD -44.422%
Emergent BioSolutions Inc. 446.5 Million USD -1370.101%
Elanco Animal Health Incorporated 5.73 Billion USD -14.435%
Perrigo Company plc 3.63 Billion USD -80.687%
Teva Pharmaceutical Industries Limited 18.48 Billion USD 64.482%